Pharma News

Scientists from the Trinity Biomedical Sciences Institute (TBSI) have shed new light on ageing processes in the brain. By linking the increased presence of specialised immune cells to conditions such as Alzheimer’s disease and traumatic brain injury for the first time, they have unearthed a possible new target for therapies aimed at treating age-related neurological diseases.

Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for naloxone hydrochloride nasal spray, USP, 4mg, which is the generic version of Narcan® and is used in the treatment of a known or suspected opioid overdose emergency.

Dr. Bharati Pravin Pawar, Minister of State inaugurates Pharma Anveshan-2023 on the occasion of National Pharmacy Education Day

Alembic Pharmaceuticals Limited announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum).

Veterinarian, immunologist, and molecular geneticist Dr. Kathy Meek and her team from the Michigan State University College of Veterinary Medicine have made a discovery that may have implications for therapeutic gene editing strategies, cancer diagnostics and therapies, and other aspects of biotechnology.

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from happening, according to new research from UTHealth Houston.

The study, led by Sandipan Pati, MD, associate professor in the Department of Neurology with McGovern Medical School at UTHealth Houston, was recently published in NEJM Evidence, a publication of the New England Journal of Medicine.

Centers for Disease Control and Prevention (CDC) US researchers said that the Gambia children deaths are associated with syrup made by Maiden Pharmaceuticals. Their investigation strongly suggests that medications contaminated with diethylene glycol (DEG) or ethylene glycol (EG) imported into The Gambia led to this acute kidney injury (AKI) cluster among children.

Hetero group to invest Rs. 1000 crore in Andhra Pradesh to expand its pharmaceutical and specialist business, said Vamsi Krishna Bandi, Managing Director of Hetero.

There was Global Investors Summit 2023 organised at Visakhapatnam where he said, "We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business. This will generate employment for a minimum of 3,000 people."

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Apixaban Tablets, 2.5 mg and 5 mg (USRLD: Eliquis® Tablets).